FR2332757A1 - Cephalosporines - Google Patents
CephalosporinesInfo
- Publication number
- FR2332757A1 FR2332757A1 FR7635341A FR7635341A FR2332757A1 FR 2332757 A1 FR2332757 A1 FR 2332757A1 FR 7635341 A FR7635341 A FR 7635341A FR 7635341 A FR7635341 A FR 7635341A FR 2332757 A1 FR2332757 A1 FR 2332757A1
- Authority
- FR
- France
- Prior art keywords
- human
- veterinary medicine
- substd
- carbamoyl
- antibacterials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 229940088710 antibiotic agent Drugs 0.000 title abstract 2
- 229940124587 cephalosporin Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- -1 heterocyclyl thio-methyl cephalosporins Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 229960003324 clavulanic acid Drugs 0.000 abstract 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB48719/75A GB1570582A (en) | 1975-11-27 | 1975-11-27 | Cephalosporins |
| GB1495276 | 1976-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2332757A1 true FR2332757A1 (fr) | 1977-06-24 |
Family
ID=26250914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7635341A Withdrawn FR2332757A1 (fr) | 1975-11-27 | 1976-11-24 | Cephalosporines |
Country Status (14)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358409A1 (fr) * | 1976-07-12 | 1978-02-10 | Smithkline Corp | Nouvelles 7-beta-oxyiminoacylphalosporines et leur application en therapeutique |
| FR2372167A1 (fr) * | 1976-08-30 | 1978-06-23 | Bristol Myers Co | Nouvelles cephalosporines, leur procede de preparation et medicament antibacterien les contenant |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53155051U (enrdf_load_stackoverflow) * | 1977-05-10 | 1978-12-06 | ||
| JPS54106495A (en) * | 1978-02-09 | 1979-08-21 | Dai Ichi Seiyaku Co Ltd | Cephem derivative |
| DK225179A (da) | 1978-06-22 | 1979-12-23 | Chugai Pharmaceutical Co Ltd | Fremgangsmaade til fremstilling af cephalosporinderivater |
-
1976
- 1976-11-17 NZ NZ182649A patent/NZ182649A/xx unknown
- 1976-11-19 IL IL50945A patent/IL50945A0/xx unknown
- 1976-11-23 FI FI763363A patent/FI763363A7/fi not_active Application Discontinuation
- 1976-11-24 SE SE7613150A patent/SE7613150L/xx unknown
- 1976-11-24 FR FR7635341A patent/FR2332757A1/fr not_active Withdrawn
- 1976-11-25 GR GR52263A patent/GR61821B/el unknown
- 1976-11-25 NO NO764034A patent/NO764034L/no unknown
- 1976-11-25 DE DE19762653621 patent/DE2653621A1/de active Pending
- 1976-11-26 DK DK536176A patent/DK536176A/da not_active Application Discontinuation
- 1976-11-26 NL NL7613243A patent/NL7613243A/xx not_active Application Discontinuation
- 1976-11-26 ES ES453722A patent/ES453722A1/es not_active Expired
- 1976-11-27 JP JP51142811A patent/JPS5278894A/ja active Pending
- 1976-11-29 AU AU20087/76A patent/AU2008776A/en not_active Expired
-
1977
- 1977-11-24 PH PH20477A patent/PH13321A/en unknown
-
1978
- 1978-12-01 ES ES475659A patent/ES475659A1/es not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358409A1 (fr) * | 1976-07-12 | 1978-02-10 | Smithkline Corp | Nouvelles 7-beta-oxyiminoacylphalosporines et leur application en therapeutique |
| FR2372167A1 (fr) * | 1976-08-30 | 1978-06-23 | Bristol Myers Co | Nouvelles cephalosporines, leur procede de preparation et medicament antibacterien les contenant |
Also Published As
| Publication number | Publication date |
|---|---|
| DK536176A (da) | 1977-05-28 |
| PH13321A (en) | 1980-03-13 |
| ES453722A1 (es) | 1979-06-01 |
| DE2653621A1 (de) | 1977-06-08 |
| IL50945A0 (en) | 1977-01-31 |
| AU2008776A (en) | 1978-06-08 |
| NZ182649A (en) | 1979-11-01 |
| NL7613243A (nl) | 1977-06-01 |
| FI763363A7 (enrdf_load_stackoverflow) | 1977-05-28 |
| JPS5278894A (en) | 1977-07-02 |
| SE7613150L (sv) | 1977-05-28 |
| NO764034L (enrdf_load_stackoverflow) | 1977-05-31 |
| ES475659A1 (es) | 1979-10-16 |
| GR61821B (en) | 1979-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ311083A (en) | Aromatic compounds and pharmaceutical compositions containing them useful as antagonists of E-type prostaglandins | |
| PT87542A (pt) | Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease | |
| LU90839I2 (fr) | Kaletra-combinaison de lopinavir et de ritonavir et ses d-riv-s pharmaceutiquement acceptables | |
| NO920740L (no) | Doseringsform for oral administrering av hypoglykemisk glipizid | |
| NO873072L (no) | Nye galeniske formuleringer med programert frigjoering inneholdende antiflogistika. | |
| IE41374B1 (en) | A composition for treating schizophrenia | |
| NZ237351A (en) | Cephalosporin derivative, medicaments, intermediate compound | |
| ES450391A1 (es) | Un procedimiento para la preparacion de derivados del acido 2-(m-fenoxifenil)-propionico. | |
| ES336645A1 (es) | Procedimiento de preparacion de nuevos derivados de la sulfonilurea. | |
| FR2332757A1 (fr) | Cephalosporines | |
| GB1515241A (en) | Beta-lactam antibiotics | |
| ITMI911101A1 (it) | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie | |
| GEP19981260B (en) | Method of obtaining substituted 1,3,4,9-tetrahydropyrano/3,4-indole-1-acetic/ acids or pharmaceutically acceptable salts thereof | |
| GB1457484A (en) | Acylamidocephalosporins | |
| FR2140420A1 (en) | Penicillin and cephalosporin oxofuryl esters - with antibacterial activity after oral administration | |
| GB1262830A (en) | Novel sydnonimine derivative | |
| GB1480003A (en) | Tricyclic dicarboximides | |
| GB1276968A (en) | Improvements in or relating to phenylacetamides and the preparation thereof | |
| GB1152627A (en) | Improvements in or relating to Oxazole Derivatives | |
| GB1504426A (en) | Clavulanic acid derivatives | |
| GB1361886A (en) | N-formyl-dl-homocysteine thiolactone and its use as a drug | |
| GB1394791A (en) | Diphenylalkyllactamimide derivatives | |
| GB1351535A (en) | Isopropylamino pyrimidine derivatives | |
| GB1507643A (en) | 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis | |
| IE45096L (en) | Thiadiazole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |